Time & Date: 2 September, 11:00 – 12:00 CEST
Chairperson: E. Midena ITALY & U. Schmidt-Erfurth AUSTRIA
Speakers & Presentations:
E. Midena ITALY
11:00 Welcome
R. Ehrlich ISRAEL
11:02 Interim clinical outcome of a novel epiretinal prosthetic device with 3D intra-retinal electrodes, the NR600 System, in end-stage Retinitis Pigmentosa patients
S. Rizzo ITALY
11:08 A novel implantation procedure and fixation technique of an epiretinal prosthetic device with an intraretinal electrode array.
E. Midena ITALY
11:14 Additional measures of visual function beyond acuity in retinal disease
T. Peto USA
11:20 Retinal phenotyping of different variants of Alzheimer’s disease using ultra-widefield imaging
J. Ruiz-Medrano UK
11:26 Involvement secondary to amyloidosis: from heart to eyes. Comparison between hereditary Transthyretin (TTR) and non-hereditary amyloidosis.
J. Penkava GERMANY
11:32 Detection of SARS‐CoV‐2‐RNA in post‐mortem samples of human eyes
E. Daniele ITALY
11:38 Denuded Descemet’s membrane as potential tool to support human embryonic stem cell derived retinal pigment epithelial cells culture
F. Behar-Cohen SWITERLAND
11:44 Glial cells of the human fovea revisited
U. Schmidt-Erfurth AUSTRIA
11:50 Identification of optimal responders to complement inhibition therapy in geographic atrophy (GA) based on optical coherence tomography (OCT)
All Faculty
11:50 Discussion
